Advances in AML: The Role of a BCL-2 Inhibitor in Current Treatment Paradigms
Released Friday, 16th December 2022
Good episode? Give it some love!
Advances in AML: The Role of a BCL-2 Inhibitor in Current Treatment Paradigms
Advances in AML: The Role of a BCL-2 Inhibitor in Current Treatment Paradigms
Friday, 16th December 2022
Good episode? Give it some love!
Rate Episode
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Harry Paul Erba, MD, PhD
Guest: Uma Borate, MD, MS
With the development of technologies paired with an enhanced understanding of the AML genomic landscape, it’s become possible to further the development of AML therapies. Joining Dr. Charles Turck to explore venetoclax and its role in current AML treatment paradigms are Drs. Uma Borate and Harry Erba.
Show More
Rate
From The Podcast
Women’s Health Update
Welcome to the Women’s Health Update series, the latest edition of ReachMD’s Advances in Women’s Health. This series offers insight to improve gynecological care for women. Experts share evidence-based opinions on a variety of topics affecting your patients including: cervical cancer screening, abnormal uterine bleeding, management of preterm birth, and sexually transmitted infections.Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Episode Tags
Do you host or manage this podcast?
Claim and edit this page to your liking.
,Claim and edit this page to your liking.
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us